Red ginseng acidic polysaccharide (RGAP), isolated from Korean red ginseng (Panax ginseng C.A. Meyer), has been shown to have a variety of biological functions such as immunostimulating and anti-tumor activities. In the present study, we investigated whether RGAP inhibited ligand-induced platelet ag...
Red ginseng acidic polysaccharide (RGAP), isolated from Korean red ginseng (Panax ginseng C.A. Meyer), has been shown to have a variety of biological functions such as immunostimulating and anti-tumor activities. In the present study, we investigated whether RGAP inhibited ligand-induced platelet aggregation. The washed platelet-rich plasma was prepared from male SD rats with successive centrifugation. The platelets $(10^8/ml)$ were preincubated with 1 mM of $CaCl_2$ for 2 min either in the presence or in the absence of RGAP $(10{\sim}50\;{\mu}g/ml)$ and were stimulated with collagen (2.5 ${\mu}g/ml$) and thrombin (0.1 U/ml). RGAP dose-dependently inhibited thrombin-induced platelet aggregation with $IC_{50}$ value of $26.2{\pm}2.0$${\mu}g/ml$. In collagen-induced platelet aggregation, RGAP inhibited the reaction with an $IC_{50}$ value of $31.5{\pm}3.0\;{\mu}g/ml$. RGAP potently suppressed the intracellular calcium ion, which was stimulated by thrombin (0.1 U/ ml). Among mitogen-activated protein kinase (MAPK) subtypes, the extracellular signal-regulated kinase (ERK) 1/2 and p38 MAPK were analyzed in the present study. RGAP inhibited the phosphorylation of ERK2 and p38 MAPK, which was activated by collagen (2.5 ${\mu}g/ml$). Finally, these results suggested that besides saponin fraction, RGAP take an important role in the preventive effect of Korean red ginseng against cardiovascular disease such as thrombosis and atherosclerosis.
Red ginseng acidic polysaccharide (RGAP), isolated from Korean red ginseng (Panax ginseng C.A. Meyer), has been shown to have a variety of biological functions such as immunostimulating and anti-tumor activities. In the present study, we investigated whether RGAP inhibited ligand-induced platelet aggregation. The washed platelet-rich plasma was prepared from male SD rats with successive centrifugation. The platelets $(10^8/ml)$ were preincubated with 1 mM of $CaCl_2$ for 2 min either in the presence or in the absence of RGAP $(10{\sim}50\;{\mu}g/ml)$ and were stimulated with collagen (2.5 ${\mu}g/ml$) and thrombin (0.1 U/ml). RGAP dose-dependently inhibited thrombin-induced platelet aggregation with $IC_{50}$ value of $26.2{\pm}2.0$${\mu}g/ml$. In collagen-induced platelet aggregation, RGAP inhibited the reaction with an $IC_{50}$ value of $31.5{\pm}3.0\;{\mu}g/ml$. RGAP potently suppressed the intracellular calcium ion, which was stimulated by thrombin (0.1 U/ ml). Among mitogen-activated protein kinase (MAPK) subtypes, the extracellular signal-regulated kinase (ERK) 1/2 and p38 MAPK were analyzed in the present study. RGAP inhibited the phosphorylation of ERK2 and p38 MAPK, which was activated by collagen (2.5 ${\mu}g/ml$). Finally, these results suggested that besides saponin fraction, RGAP take an important role in the preventive effect of Korean red ginseng against cardiovascular disease such as thrombosis and atherosclerosis.
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
문제 정의
Moreover, RGAP displayed anti-tumor activity in vitro and in vivo22, 24). This study was undertaken to determine whether RGAP mod ulates platelet aggregation, in comparison with ginsenos- ide Rg3 that is a known anti-platelet component of red ginseng25). First the anti-platelet properties of RGAP were investigated using a platelet aggregation assay that was induced by collagen and thrombin.
대상 데이터
RGAP was obtained from KT & G Central Research Institute (Daqjon, Korea). Thrombin and Fura-2/AM were obtained from Sigma Co (St.
데이터처리
The One-way ANOVA method was used to determine the statistical significance of differences. P values of 0.
이론/모형
Platelet extracts were prepared by standard Laemmli method 27). After the platelet aggregation assay, the sam ple buffer (0.
참고문헌 (39)
Maguire, P. B., Moran, N., Cagney, G. and Fitzgerald, D. J. : Application of proteomics to the study of platelet regulatory mechanisms. Trends Cardiovasc Med. 14, 207-220 (2004).
Macaulay, I. C., Carr, P., Gusnanto, A., Ouwehand, W. H., Fitzgerald, D. and Watkins, N. A. : Platelet genomics and proteomics in human health and disease. J Clin Invest. 115, 3370-3377 (2005).
Lee, J. J., Jin, Y. R., Lim, Y., Hong, J. T., Kim, T. J., Chung, J. H. and Yun, Y. P. : Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization. Vascul Pharmacol 45, 148-153 (2006).
el-Daher, S. S., Eigenthaler, M., Walter, U., Furuichi, T., Miyawaki, A., Mikoshiba, K., Kakkar, V. V. and Authi, K. S. : Distribution and activation of cAMP- and cGMP-dependent protein kinases in highly purified human platelet plasma and intracellular membranes. Thromb Haemost. 76, 1063- 1071 (1996).
Jang, E. K., Azzam, J. E., Dickinson, N. T., Davidson, M. M. and Haslam, R. J. : Roles for both cyclic GMP and cyclic AMP in the inhibition of collagen-induced platelet aggregation by nitroprusside. Br J Haematol 117, 664-675 (2002).
Radomski, M. W., Palmer, R. M. and Moncada, S. : Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2, 1057-1058 (1987).
Liao, C. H., Tzeng, C. C. and Teng, C. M. : Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl) methoxy)quinol inone (CCT-62). Eur J Pharmacol 349, 107- 114 (1998).
Yao, J., Zhu, Y., Sun, W., Sawada, N., Hiramatsu, N., Takeda, M. and Kitamura, M. : Irsogladine maleate potentiates the effects of nitric oxide on activation of cAMP signalling pathways and suppression of mesangial cell mitogenesis. Br J Pharmacol. 151, 457-466 (2007).
Manns, J. M., Brenna, K. J., Colman, R. W. and Sheth, S. B. : Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases. Thromb Haemost. 87, 873-879 (2002).
Smith, J. B., Selak, M. A., Dangelmaier, C. and Daniel, J. L. : Cytosolic calcium as a second messenger for collageninduced platelet responses. Biochem J 288, 925-929 (1992).
Park, H. J., Rhee, M. H., Park, K. M., Nam, K. Y. and Park, K. H. : Effect of non-saponin fraction from Panax ginseng on cGMP and thromboxane A2 in human platelet aggregation. J Ethnopharmacol. 49, 157-162 (1995).
Kim, E. H., Park, J. D., Pyo, S. N. and Rhee, D. K. : Effects of non-saponin red ginseng components on multi-drug resistance. J Ginseng Res 31, 74-78 (2007).
Kwak, Y. S., Shin, H. J., Song, Y. B., Kyung, J. S., Wee, J. J. and Park, J. D. : Effect of oral administration of red ginseng acidic polysaccharide on the tumor growth inhibition. J Ginseng Res 29, 176-181 (2005).
Park, K. M., Kim, Y. S., Jeong, T. C., Joe, C. O., Shin, H. J., Lee, Y. H., Nam, K. Y. and Park, J. D. : Nitric oxide is involved in the immunomodulating activities of acidic polysaccharide from Panax ginseng. Planta Med. 67, 122- 126 (2001).
Shin, H. J., Kim, Y. S., Kwak, Y. S., Song, Y. B., Kyung, J. S., Wee, J. J. and Park, J. D. : A further study on the inhibition of tumor growth and metastasis by red ginseng acidic polysaccharide (RGAP). Natural Product Sci 10, 284-288 (2004).
Lee, S. R., Park, J. H., Choi, K. J. and Kim, N. D. : Inhibitory effects of ginsenoside Rg3 on platelet aggregation and its mechanism of action. Korean J. Ginseng Sci. 21, 132-140 (1997).
Kim, S. D., Park, S. K., Cho, J. Y., Park, H. J., Lim, J. H., Yun, H. I., Park, S. C., Lee, K. Y., Kim, S. K. and Rhee, M. H. : Surfactin C inhibits platelet aggregation. J Pharm Pharmacol. 58, 867-870 (2006).
Park, H. J., Rhee, M. H., Park, K. M., Nam, K. Y. and Park, K. H. : Effect of non-saponin fraction from Panax ginseng on cGMP and thromboxane A2 in human platelet aggregation. J Ethnopharmacol 49, 157-162 (1995).
Roberts, D. E., McNicol, A. and Bose, R. : Mechanism of collagen activation in human platelets. J Biol Chem 279, 19421-19430. Epub 12004 Feb 19423 (2004).
Farndale, R. W., Sixma, J. J., Barnes, M. J. and de Groot, P. G. : The role of collagen in thrombosis and hemostasis. J Thromb Haemost 2, 561-573 (2004).
Rosado, J. A. and Sage, S. O. : The ERK cascade, a new pathway involved in the activation of store-mediated calcium entry in human platelets. Trends Cardiovasc Med 12, 229-234 (2002).
Borsch-Haubold, A. G., Kramer, R. M. and Watson, S. P. : Cytosolic phospholipase A2 is phosphorylated in collagenand thrombin-stimulated human platelets independent of protein kinase C and mitogen-activated protein kinase. J Biol Chem 270, 25885-25892 (1995).
Mazharian, A., Roger, S., Maurice, P., Berrou, E., Popoff, M. R., Hoylaerts, M. F., Fauvel-Lafeve, F., Bonnefoy, A. and Bryckaert, M. : Differential Involvement of ERK2 and p38 in platelet adhesion to collagen. J Biol Chem 280, 26002- 26010 (2005).
Roger, S., Pawlowski, M., Habib, A., Jandrot-Perrus, M., Rosa, J. P. and Bryckaert, M. : Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation. FEBS Lett 556, 227-235 (2004).
Rosado, J. A. and Sage, S. O. : Role of the ERK pathway in the activation of store-mediated calcium entry in human platelets. J Biol Chem 276, 15659-15665 (2001).
Garcia, A., Shankar, H., Murugappan, S., Kim, S. and Kunapuli, S. P. : Regulation and functional consequences of ADP receptor- mediated ERK2 activation in platelets. Biochem J. 404, 299-308 (2007).
McNicol, A. and Jackson, E. C. : Inhibition of the MEK/ ERK pathway has no effect on agonist-induced aggregation of human platelets. Biochem Pharmacol 65, 1243-1250 (2003).
※ AI-Helper는 부적절한 답변을 할 수 있습니다.